Metformin: What Nobody Warns You About

Metformin is one of the most commonly prescribed medications for type 2 diabetes, yet many people still have questions and concerns about what it may be doing inside their body, especially when it comes to the kidneys.

Does metformin actually damage your kidneys? Why do doctors check kidney function before and during treatment? What do numbers like eGFR and creatinine have to do with metformin? And are there situations where continuing the medication could become risky?

In this video, we take a closer look at the real relationship between metformin and kidney function. We’ll discuss why kidney health matters when taking metformin, what doctors are monitoring, when a dose may need to be adjusted, and why certain kidney problems can change how safely your body handles the medication.

We’ll also separate some of the most common metformin myths from the concerns that actually deserve your attention. Understanding the difference can help you have a much more informed conversation with your healthcare provider about your diabetes treatment.

If you currently take metformin, have recently been prescribed it, or have been worried about your kidney numbers, this video will help you better understand what those results may mean and why your doctor monitors them.

Never stop or change a prescription medication without discussing it with your healthcare provider.

Looking for expert guidance on thyroid health, hormone balance, metabolism, and related symptoms?
Visit our dedicated thyroid and hormone YouTube channels for practical, physician-led education:
The Hormone Clinic
https://www.youtube.com/@TheHormoneClinic
Thyroid Doctor
https://www.youtube.com/@thyroiddoctor6778
Subscribe to both channels and turn on notifications so you do not miss our latest videos on thyroid disorders, Hashimoto’s disease, hypothyroidism, hormone replacement, menopause, testosterone, fatigue, weight management, and metabolic health.
These channels provide general education and are not a substitute for personalized medical care.

References :

References
• Metformin Treatment for Patients with Diabetes and Chronic Kidney Disease (eGFR thresholds) — https://pmc.ncbi.nlm.nih.gov/articles/PMC7043977/[pmc.ncbi.nlm.nih]
• Possible Side Effects of Metformin Use, Cleveland Clinic ConsultQD (2016 label revision) — https://consultqd.clevelandclinic.org/possible-side-effects-of-metformin-use-in-patients-with-type-2-diabetes[consultqd.clevelandclinic]
• Metformin-Associated Lactic Acidosis, StatPearls/NCBI — https://www.ncbi.nlm.nih.gov/books/NBK580485/[ncbi.nlm.nih]
• Risk of Fatal and Nonfatal Lactic Acidosis With Metformin, JAMA Internal Medicine — https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/216377[jamanetwork]
• Salpeter et al., pooled 347 studies, zero lactic acidosis cases in 70,490 patient-years — https://pmc.ncbi.nlm.nih.gov/articles/PMC7138050/[pmc.ncbi.nlm.nih]
• Metformin associated lactic acidosis: incidence and clinical correlation — https://pubmed.ncbi.nlm.nih.gov/21545617/[pubmed.ncbi.nlm.nih]
• Significance of Metformin Use in Diabetic Kidney Disease (mortality and ESRD outcomes) — https://pmc.ncbi.nlm.nih.gov/articles/PMC7352798/[pmc.ncbi.nlm.nih]
• Role of Metformin in Preventing New-Onset Chronic Kidney Disease — https://www.mdpi.com/1424-8247/18/1/95[mdpi]
• Vitamin B12 Deficiency and Clinical Neuropathy with Metformin Use — https://pmc.ncbi.nlm.nih.gov/articles/PMC9225352/[pmc.ncbi.nlm.nih]
• Long-term metformin use, B12 deficiency and neuropathy, All of Us Research Program — https://pubmed.ncbi.nlm.nih.gov/40850508/[pubmed.ncbi.nlm.nih]
• MASTERS Trial: Metformin Blunts Muscle Hypertrophy with Resistance Training in Older Adults — https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1008&context=ccts_facpub[uknowledge.uky]
• Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan — https://journals.physiology.org/doi/full/10.1152/physiol.00013.2020[journals.physiology]
• Efficacy of Berberine in Patients with Type 2 Diabetes (Yin et al.) — https://pmc.ncbi.nlm.nih.gov/articles/PMC2410097/[pmc.ncbi.nlm.nih]
• Metformin and berberine, two versatile drugs in treatment of metabolic syndrome — https://pmc.ncbi.nlm.nih.gov/articles/PMC5839379/[pmc.ncbi.nlm.nih]
• Absorption Kinetics of Berberine and Dihydroberberine in Humans — https://pmc.ncbi.nlm.nih.gov/articles/PMC8746601/[pmc.ncbi.nlm.nih]
• Differences in Metabolite Profiles of Dihydroberberine and Micronized Berberine — https://pmc.ncbi.nlm.nih.gov/articles/PMC11171481/[pmc.ncbi.nlm.nih]
• Pathogenesis of Diabetic Nephropathy, NCBI — https://www.ncbi.nlm.nih.gov/books/NBK571720/[ncbi.nlm.nih]
• Acute kidney injury in diabetic patients: a narrative review — https://pmc.ncbi.nlm.nih.gov/articles/PMC10219694/[pmc.ncbi.nlm.nih]